lung cancer
Conditions
Interventions
lung adenocarcinoma:chemotherapy or target therapy
small cell lung cancer:chemotherapy
Sponsors
Beijing Chao-Yang Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Every participant must sign an informed consent before participating in the trial; 2. Every patient must be newly diagnosed histologically or cytologically confirmed lung adenocarcinoma with stage IIIB, VI or small cell lung cancer; 3. Both male and female patients with aged 18 years or older, performance score ECOG 0 to 2, the expected survival >=3 months.
Exclusion criteria
Exclusion criteria: 1. No cytological or histological evidence; 2. The patients had already received chemotherapy, radiotherapy, target therapy or immune therapy ; 3. The patients with heart, lung, liver, kidney function insufficiency ; 4. The patients had previous other tumor history (except with cured cervical carcinoma in situ or local basal cell carcinoma of skin); 5. The researchers do not think that patients should participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T helper lymphocyte; | — |
Secondary
| Measure | Time frame |
|---|---|
| objective response rate;progression-free survival;overall survival; | — |
Contacts
Public ContactShi Huanzhong,Zhang Yuhui
Outcome results
None listed